GENVOYA FDA approval date

The FDA approved GENVOYA on 5 Nov 2015.

FDA approval date
5 Nov 2015

Drug identity has not yet been verified against registry records

Also recorded as COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2015-11-05DayGENVOYAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207561", "applicant_as_listed_by_fda": "GILEAD SCIENCES INC", "brand_names": ["GENVOYA"], "active_ingredients": ["COBICISTAT", "ELVITEGRAVIR", "EMTRICITABINE", "TENOFOVIR ALAFENAMIDE FUMARATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151105", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026